2026/05/25 更新

お知らせ

 

写真a

タカシマ マサミツ
高島 正光
TAKASHIMA MASAMITSU
バナー付きURL
所属
九州大学病院 腎・高血圧・脳血管内科 助教
職名
助教
連絡先
メールアドレス
ホームページ

研究分野

  • ライフサイエンス / 神経科学一般

学位

  • 医学博士(甲) ( 2023年3月 九州大学 )

論文

  • <i>RNF213 </i>p.R4810K Variant and Intracranial Atherosclerosis: Increased Risk in Obese Variant Carriers 査読 国際誌

    Takashima, M; Kiyohara, T; Nakamura, K; Ozaki, Y; Yoshino, F; Hashimoto, G; Hidaka, M; Sahara, N; Irie, F; Wakisaka, Y; Matsuo, R; Kamouchi, M; Kitazono, T; Ago, T

    JOURNAL OF STROKE   28 ( 1 )   172 - 175   2026年1月   ISSN:2287-6391 eISSN:2287-6405

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Journal of Stroke  

    DOI: 10.5853/jos.2025.02607

    Web of Science

    Scopus

    PubMed

  • Low-dose sodium-glucose cotransporter 2 inhibitor ameliorates ischemic brain injury in mice through pericyte protection without glucose-lowering effects 査読 国際誌

    Takashima, M; Nakamura, K; Kiyohara, T; Wakisaka, Y; Hidaka, M; Takaki, H; Yamanaka, K; Shibahara, T; Wakisaka, M; Ago, T; Kitazono, T

    COMMUNICATIONS BIOLOGY   5 ( 1 )   653   2022年7月   eISSN:2399-3642

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Communications Biology  

    Antidiabetic sodium-glucose cotransporter 2 (SGLT2) inhibitors have attracted attention for their cardiorenal-protective properties beyond their glucose-lowering effect. However, their benefits in ischemic stroke remain controversial. Here we show the effects of luseogliflozin, a selective SGLT2 inhibitor, in acute ischemic stroke, using a permanent middle cerebral artery occlusion (pMCAO) model in non-diabetic mice. Pretreatment with low-dose luseogliflozin, which does not affect blood glucose levels, significantly attenuated infarct volume, blood-brain barrier disruption, and motor dysfunction after pMCAO. SGLT2 was expressed predominantly in brain pericytes and was upregulated in peri- and intra-infarct areas. Notably, luseogliflozin pretreatment reduced pericyte loss in ischemic areas. In cultured pericytes, luseogliflozin activated AMP-activated protein kinase α and increased mitochondrial transcription factor A expression and number of mitochondria, conferring resistance to oxygen-glucose deprivation. Collectively, pre-stroke inhibition of SGLT2 induces ischemic tolerance in brain pericytes independent of the glucose-lowering effect, contributing to the attenuation of ischemic brain injury.

    DOI: 10.1038/s42003-022-03605-4

    Web of Science

    Scopus

    PubMed

  • PDGFRβ-positive cell-mediated post-stroke remodeling of fibronectin and laminin α2 for tissue repair and functional recovery 査読 国際誌

    Shibahara, T; Nakamura, K; Wakisaka, Y; Shijo, M; Yamanaka, K; Takashima, M; Takaki, H; Hidaka, M; Kitazono, T; Ago, T

    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM   43 ( 4 )   518 - 530   2023年4月   ISSN:0271-678X eISSN:1559-7016

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Journal of Cerebral Blood Flow and Metabolism  

    Post-stroke intra-infarct repair promotes peri-infarct neural reorganization leading to functional recovery. Herein, we examined the remodeling of extracellular matrix proteins (ECM) that constitute the intact basal membrane after permanent middle cerebral artery occlusion (pMCAO) in mice. Among ECM, collagen type IV remained localized on small vessel walls surrounding CD31-positive endothelial cells within infarct areas. Fibronectin was gradually deposited from peri-infarct areas to the ischemic core, in parallel with the accumulation of PDGFRβ-positive cells. Cultured PDGFRβ-positive pericytes produced fibronectin, which was enhanced by the treatment with PDGF-BB. Intra-infarct deposition of fibronectin was significantly attenuated in pericyte-deficient Pdgfrb<sup>+/−</sup> mice. Phagocytic activity of macrophages against myelin debris was significantly enhanced on fibronectin-coated dishes. In contrast, laminin α2, produced by GFAP- and aquaporin 4-positive astrocytes, accumulated strongly in the boundary of peri-infarct areas. Pericyte-conditioned medium increased the expression of laminin α2 in cultured astrocytes, partly through TGFβ1. Laminin α2 increased the differentiation of oligodendrocyte precursor cells into oligodendrocytes and the expression of myelin-associated proteins. Peri-infarct deposition of laminin α2 was significantly reduced in Pdgfrb<sup>+/−</sup> mice, with attenuated oligodendrogenesis in peri-infarct areas. Collectively, intra-infarct PDGFRβ-positive cells may orchestrate post-stroke remodeling of key ECM that create optimal environments promoting clearance of myelin debris and peri-infarct oligodendrogenesis.

    DOI: 10.1177/0271678X221145092

    Web of Science

    Scopus

    PubMed

  • Deletion of Nox4 enhances remyelination following cuprizone-induced demyelination by increasing phagocytic capacity of microglia and macrophages in mice 査読 国際誌

    Yamanaka, K; Nakamura, K; Shibahara, T; Takashima, M; Takaki, H; Hidaka, M; Komori, M; Yoshikawa, Y; Wakisaka, Y; Ago, T; Kitazono, T

    GLIA   71 ( 3 )   541 - 559   2023年3月   ISSN:0894-1491 eISSN:1098-1136

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:GLIA  

    NOX4 is a major reactive oxygen species-producing enzyme that modulates cell stress responses. We here examined the effect of Nox4 deletion on demyelination–remyelination, the most common pathological change in the brain. We used a model of cuprizone (CPZ)-associated demyelination–remyelination in wild-type and Nox4-deficient (Nox4<sup>−/−</sup>) mice. While the CPZ-induced demyelination in the corpus callosum after 4 weeks of CPZ intoxication was slightly less pronounced in Nox4<sup>−/−</sup> mice than that in wild-type mice, remyelination following CPZ withdrawal was significantly enhanced in Nox4<sup>−/−</sup> mice with an increased accumulation of IBA1-positive microglia/macrophages in the demyelinating corpus callosum. Consistently, locomotor function, as assessed by the beam walking test, was significantly better during the remyelination phase in Nox4<sup>−/−</sup> mice. Nox4 deletion did not affect autonomous growth of primary-culture oligodendrocyte precursor cells. Although Nox4 expression was higher in cultured macrophages than in microglia, Nox4<sup>−/−</sup> microglia and macrophages both showed enhanced phagocytic capacity of myelin debris and produced increased amounts of trophic factors upon phagocytosis. The expression of trophic factors was higher, in parallel with the accumulation of IBA1-positive cells, in the corpus callosum in Nox4<sup>−/−</sup> mice than that in wild-type mice. Nox4 deletion suppressed phagocytosis-induced increase in mitochondrial membrane potential, enhancing phagocytic capacity of macrophages. Treatment with culture medium of Nox4<sup>−/−</sup> macrophages engulfing myelin debris, but not that of Nox4<sup>−/−</sup> astrocytes, enhanced cell growth and expression of myelin-associated proteins in cultured oligodendrocyte precursor cells. Collectively, Nox4 deletion promoted remyelination after CPZ-induced demyelination by enhancing microglia/macrophage-mediated clearance of myelin debris and the production of trophic factors leading to oligodendrogenesis.

    DOI: 10.1002/glia.24292

    Web of Science

    Scopus

    PubMed

講演・口頭発表等

▼全件表示

MISC

共同研究・競争的資金等の研究課題

  • ペリサイトにおけるSGLT2に着目した脳血管性認知症に対する新規治療法の開発

    研究課題/領域番号:23K19593  2023年8月 - 2025年3月

    科学研究費助成事業  研究活動スタート支援

    高島 正光

      詳細を見る

    資金種別:科研費

    近年、SGLT2阻害薬は血糖降下作用以外の多彩な効果が着目されているが、脳虚血病態に対する直接的な作用についてはほとんど解明されていない。申請者等は脳血管ペリサイトがSGLT2を発現すること、SGLT2阻害薬がペリサイトに虚血耐性をもたらし、脳梗塞に伴う血液脳関門の破綻、さらには組織傷害・機能障害を抑制することを見出した。本研究課題では、脳低灌流によるマウス認知症モデルを用いて、SGLT2阻害薬が慢性脳虚血に対してペリサイトおよびNVUの維持に関与するかどうかを検証し、慢性脳虚血および認知症に対する新しい治療戦略を探索する。

    CiNii Research